MYCO-TRIACET II Drug Patent Profile
When do Myco-triacet Ii patents expire, and when can generic versions of Myco-triacet Ii launch?
Myco-triacet Ii is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in MYCO-TRIACET II is nystatin; triamcinolone acetonide. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Myco-triacet Ii
A generic version of MYCO-TRIACET II was approved as nystatin; triamcinolone acetonide by FOUGERA PHARMS INC on October 8th, 1985.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MYCO-TRIACET II?
- What are the global sales for MYCO-TRIACET II?
- What is Average Wholesale Price for MYCO-TRIACET II?
Summary for MYCO-TRIACET II
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| DailyMed Link: | MYCO-TRIACET II at DailyMed |
US Patents and Regulatory Information for MYCO-TRIACET II
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva | MYCO-TRIACET II | nystatin; triamcinolone acetonide | CREAM;TOPICAL | 061954-002 | Sep 20, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva | MYCO-TRIACET II | nystatin; triamcinolone acetonide | OINTMENT;TOPICAL | 062045-002 | Nov 26, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
